Accessibility Statement Skip Navigation
  • Resources
  • Blog
  • Journalists
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • Arabic
      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Overview
  • Distribution by PR Newswire
  • AI Tools
  • Multichannel Amplification
  • Guaranteed Paid Placement
  • SocialBoost
  • All Products
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • Overview
  • Distribution by PR Newswire
  • AI Tools
  • Multichannel Amplification
  • SocialBoost
  • All Products
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS

Onkologické podujatia v Poľsku upevňujú spoluprácu s NCCN
  • USA - English
  • USA - Pусский
  • USA - Français
  • USA - Polski
  • USA - čeština
  • USA - español
  • USA - Deutsch
  • USA - English

NCCN Logo (C)NCCN(R) 2018. All rights reserved.

News provided by

National Comprehensive Cancer Network

May 21, 2024, 03:03 ET

Share this article

Share toX

Share this article

Share toX

Organizácia National Comprehensive Cancer Network sa zúčastňuje na stretnutiach, ktoré organizuje Maria Sklodowska-Curie National Research Institute of Oncology, Polish Oncological Society a Alliance for Innovation s cieľom dosiahnuť pokroky v prispôsobovaní osvedčených usmernení pre liečbu rakoviny v Poľsku.

VARŠAVA, Poľsko, 21. mája 2024 /PRNewswire/ -- National Comprehensive Cancer Network® (NCCN®) – globálna nezisková organizácia zodpovedná za popredné usmernenia v liečbe rakoviny – sa zúčastňuje na dvoch podujatiach vo Varšave v čase od 21. do 22. mája 2024 zameraných na pokrok v starostlivosti o pacientov s rakovinou a zdôrazňujúcich bilaterálne úspechy Poľska a USA v oblasti zdravotnej starostlivosti. Podujatia bude organizovať Maria Sklodowska-Curie National Research Institute of Oncology, Polish Oncological Society a Alliance for Innovation. Vystúpi výkonná riaditeľka NCCN, Crystal S. Denlinger, MD, spolu s Katy Winckworth-Prejsnar, MPH, senior manažérkou globálneho programu NCCN.

Continue Reading
Photo of NCCN CEO Crystal S. Denlinger, MD, with oncology experts at the Polish Embassy, November 2021.
Photo of NCCN CEO Crystal S. Denlinger, MD, with oncology experts at the Polish Embassy, November 2021.

„Je nám cťou, že môžeme prispieť k ambicióznej poľskej národnej onkologickej stratégii," povedala Dr. Denlinger. „Od začiatku našej spolupráce sme dokázali spoločne prispôsobovať usmernenia NCCN pre šesť typov rakoviny regionálnym podmienkam šitým na mieru pre potreby a realitu ľudí s rakovinou v poľskom regióne. Bolo mi cťou pracovať spolu s toľkými zanietenými a skúsenými poľskými a americkými lídrami na tejto spoločnej misii zlepšovať liečbu rakoviny pre všetkých."

Šesť existujúcich úprav vychádza z odborného konsenzu NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) založeného na dôkazoch. Sú k dispozícii bezplatne na adrese NCCN.org/global alebo prostredníctvom aplikácie Virtual Library of NCCN Guidelines®.

NCCN sa bude podieľať na niekoľkých aktivitách, vrátane plánov na aktualizáciu troch európskych vydaní NCCN – Poľsko, pre oblasti:

  • Rakovina krčka maternice
  • Rakovina hrubého čreva
  • Rakovina vaječníkov/rakovina vajíčkovodov/primárny peritoneálny karcinóm

Organizácie tiež začnú pracovať na nových európskych vydaniach NCCN – Poľsko pre oblasti:

  • Onkológia dospievajúcich a mladých dospelých (AYA)
  • Análny karcinóm
  • Rakovina konečníka
  • Novotvary maternice
  • Rakovina vulvy

Boli vydané aj ďalšie európske vydania NCCN – Poľsko pre oblasti:

  • Rakovina prsníka
  • Rakovina centrálneho nervového systému
  • Rakovina hlavy a krku

„Štúdie často ilustrujú význam štandardizácie starostlivosti, aby sa zabezpečilo, že každý človek s rakovinou dostane liečbu na základe najlepších dostupných dôkazov," povedal Piotr Rutkowski, MD, PhD, predseda ministerského tímu pre národnú onkologickú stratégiu v Poľsku. „Táto spolupráca s NCCN je mimoriadne cenná pre naše úsilie o pokroky v liečbe, výskume a prevencii rakoviny v našej krajine. Sme radi, že môžeme nadviazať na naše úspechy pri ďalšej spoločnej činnosti v oblasti zdravotnej starostlivosti do budúcnosti."

NCCN v súčasnosti ponúka viac ako 20 globálnych adaptácií usmernení NCCN a viac ako 270 prekladov klinických zdrojov do viac ako 50 jazykov. Viac informácií o práci NCCN na zlepšovaní starostlivosti o pacientov s rakovinou na celom svete nájdete na stránke NCCN.org/global.

O National Comprehensive Cancer Network
National Comprehensive Cancer Network® (NCCN®) je nezisková aliancia popredných onkologických centier, oddaných starostlivosti o pacientov, výskumu a vzdelávaniu. NCCN sa venuje zlepšovaniu a uľahčovaniu kvalitnej, efektívnej, spravodlivej a dostupnej starostlivosti o pacientov s rakovinou, aby všetci mohli žiť lepší život. Usmernenia NCCN pre klinickú prax v onkológii (NCCN Guidelines®) poskytujú transparentné odporúčania odborného konsenzu pre liečbu rakoviny, prevenciu a podporné služby založené na dôkazoch. Predstavujú uznávaný štandard pre klinické smerovanie a zásady v manažmente rakoviny a najdôkladnejšie a často aktualizované usmernenia pre klinickú prax, ktoré sú k dispozícii v akejkoľvek oblasti medicíny. Usmernenia pre pacientov (NCCN Guidelines for Patients®) poskytujú odborné informácie o liečbe rakoviny s cieľom informovať a podporiť pacientov a ich opatrovateľov prostredníctvom podpory nadácie NCCN Foundation®. NCCN tiež rozvíja ďalšie vzdelávanie, globálne iniciatívy, zásady a výskumnú spoluprácu a publikovanie v onkológii. Viac informácií nájdete na stránke NCCN.org.

Kontakt pre médiá: 
Rachel Darwin
267-622-6624
[email protected] 

Foto: https://mma.prnewswire.com/media/2414294/Denlinger_Polish_Embassy.jpg 

Logo: https://mma.prnewswire.com/media/441768/NCCN_Logo.jpg

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

icon3
440k+
Newsrooms &
Influencers
icon1
9k+
Digital Media
Outlets
icon2
270k+
Journalists
Opted In
GET STARTED

Modal title

Also from this source

Una nueva investigación en JNCCN ofrece seguridad sobre el pronóstico del cáncer de próstata localizado

Una nueva investigación en JNCCN ofrece seguridad sobre el pronóstico del cáncer de próstata localizado

Una nueva investigación publicada en la edición de julio de 2025 de JNCCN—Journal of the National Comprehensive Cancer Network revela que, en el caso ...

Neue Forschung in JNCCN bietet Gewissheit über die Prognose von lokalisiertem Prostatakrebs

Neue Forschung in JNCCN bietet Gewissheit über die Prognose von lokalisiertem Prostatakrebs

Neue Forschungsergebnisse, die in der Juli-Ausgabe 2025 des JNCCN—Journal of the National Comprehensive Cancer Network veröffentlicht wurden, zeigen, ...

More Releases From This Source

Explore

Health Care & Hospitals

Health Care & Hospitals

Medical Pharmaceuticals

Medical Pharmaceuticals

Trade Show News

Trade Show News

Not For Profit

Not For Profit

News Releases in Similar Topics

Contact PR Newswire

  • Call PR Newswire at 888-776-0942
    from 8 AM - 9 PM ET
  • Chat with an Expert
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • All Products

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Become a Channel Partner
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Italy
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • Vietnam

My Services

  • All New Releases
  • Platform
  • ProfNet
  • Data Privacy

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Platform
  • ProfNet
Call PR Newswire at
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookies
Copyright © 2025 Cision US Inc.